chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lost sense of smell; oxygen dropped; more than 36 days between first and second dose; tested positive for covid again; weakness; cough; tested positive for covid; headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), COVID-19 (tested positive for covid), COVID-19 (tested positive for covid again), ASTHENIA (weakness) and ANOSMIA (lost sense of smell) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced COUGH (cough), COVID-19 (tested positive for covid), ASTHENIA (weakness) and HEADACHE (headache). On 11-Apr-2021, the patient experienced COVID-19 (tested positive for covid again). On an unknown date, the patient experienced ANOSMIA (lost sense of smell), OXYGEN CONSUMPTION DECREASED (oxygen dropped) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (more than 36 days between first and second dose). The patient was treated with VITAMINS NOS at an unspecified dose and frequency. At the time of the report, COUGH (cough), COVID-19 (tested positive for covid), COVID-19 (tested positive for covid again), ASTHENIA (weakness), ANOSMIA (lost sense of smell), OXYGEN CONSUMPTION DECREASED (oxygen dropped), HEADACHE (headache) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (more than 36 days between first and second dose) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, Oxygen saturation: 94 (abnormal) dropped to 94% and 96 (abnormal) but then improved around 96%. On 23-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive. On 11-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products included high blood pressure medication and blood sugar medication.
5cm x 7cm hive rxn @ local site of vax, onset approx 6-8hr p/vax;
Painful and I cannot lift it again; At night it woke me up; Woke me up because it's painful and I cannot lift it again; Injection site pain; Injection site pain and swelling; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Painful and I cannot lift it again), SLEEP DISORDER (At night it woke me up), LIMB DISCOMFORT (Woke me up because it's painful and I cannot lift it again), VACCINATION SITE PAIN (Injection site pain) and VACCINATION SITE SWELLING (Injection site pain and swelling) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition found).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 D-antigen units. On 12-Jan-2021, the patient experienced PAIN IN EXTREMITY (Painful and I cannot lift it again), SLEEP DISORDER (At night it woke me up), LIMB DISCOMFORT (Woke me up because it's painful and I cannot lift it again), VACCINATION SITE PAIN (Injection site pain) and VACCINATION SITE SWELLING (Injection site pain and swelling). At the time of the report, PAIN IN EXTREMITY (Painful and I cannot lift it again), LIMB DISCOMFORT (Woke me up because it's painful and I cannot lift it again), VACCINATION SITE PAIN (Injection site pain) and VACCINATION SITE SWELLING (Injection site pain and swelling) had not resolved and SLEEP DISORDER (At night it woke me up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient took Ibuprofen but it was not working.
Fridge temp went out of range by 4 degrees overnight sunday due to storm, DOH closed on 1/17. Vaccines were administered to patients in the morning
per report received. it appears patient was a resident of long term acute care facility. 1/9/2022 became feverish, shaky and hypoxic. patient was diagnosed with  COVID-19 and it was determined that patient was terminal. Patient was transferred to Hospice. Comfort measures including parentally controlled substances per order. Patient died 1/11/2022 at 04:15
pink at the injection site; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (pink at the injection site) and PYREXIA (slight fever) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     The patient's past medical history included Duodenal ulcer and Thyroidectomy (4 years ago). Concomitant products included LEVOTHYROXINE for an unknown indication.   On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (pink at the injection site) and PYREXIA (slight fever). The patient was treated with Manual therapy (using heating pan) for Injection site erythema. At the time of the report, INJECTION SITE ERYTHEMA (pink at the injection site) and PYREXIA (slight fever) outcome was unknown.            Treatment medication included using heating pan to help with the pink at injection site, Tylenol. Some medication used for duodenal ulcer.  Patient reported that Symptoms resumed after 2 days.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow up received on 3-MAY-2021 : Non pharmacological treatment updated for the event pink at the injection site.
The pt had prickly itching from elbows to shoulders on both arms, spreading to chest, neck. Has "sores" from scratching. Pressure in chest lately.
pt experienced swelling and redness at the site. This worsend into itching and then pain. pt went to the ER and had a follow up appt with us the next day.
Headache, Temperature  100.6, Body Ache in all joints, severe pain in left arm at injection site, overall weakness, no appetite, high heart beat, blood pressure high,
Information has been received from a medical assistant referring to a male (reported as "his") patient of unknown age. Information about concomitant medication, drug reactions/allergies and pertinent medical history was not provided. On 09-NOV-2011, the patient received his 1st dose of VAQTA (strength was reported as 25/0.5 without unit; route, lot# and expiration date were not reported) for prophylaxis. On 23-APR-2012, the patient received his 2nd dose of VAQTA (strength was reported as 25/0.5 without unit; route, lot# and expiration date were not reported) for prophylaxis (Inappropriate schedule of product administration). The exact dose was unknown but it was a pediatric dose. No adverse effects reported.
Patient reported bloody nose on Friday night. It didn't stop bleeding for about 45 minutes. Patient also reported blood in stool. Pt states that he does not have a hx of bloody nose.
dead arm; stomach upset; sore in her left arm; nauseous; headache; This spontaneous case was reported by a physician and describes the occurrence of HYPOAESTHESIA (dead arm), ABDOMINAL DISCOMFORT (stomach upset), PAIN IN EXTREMITY (sore in her left arm), NAUSEA (nauseous) and HEADACHE (headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced HYPOAESTHESIA (dead arm), ABDOMINAL DISCOMFORT (stomach upset), PAIN IN EXTREMITY (sore in her left arm), NAUSEA (nauseous) and HEADACHE (headache). At the time of the report, HYPOAESTHESIA (dead arm), ABDOMINAL DISCOMFORT (stomach upset), PAIN IN EXTREMITY (sore in her left arm), NAUSEA (nauseous) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Follow up received on 29-Jun-2021, included no new information.
58 yo woman received Pnu-Imune 23OC89. Arm became red w/swelling down to elbow. Subsided and no further c/o. 8DEC89 c/o of pain lt deltoid & shoulder w limitation of motion. Pt had history of stroke and poorly controlled diabetes.
Headache, fever, body aches, for approx 48 hours .  Began approx 8 hours after 2nd moderne vaccine.
Chest pain-radiating pain on right arm; Chest pain-radiating pain on right arm Went to the emergency room-14Mar2021; This is a spontaneous report from a contactable consumer (patient). A 27-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Eng199 and expiration date not provided) via an unspecified route of administration, administered in left arm on 12Mar2021 10:30 as a single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient is not pregnant. The patient has no known allergies. Concomitant medications included fluoxetine hydrochloride (PROZAC) and ethinylestradiol, ferrous fumarate, norethisterone acetate (BLISOVI FE 1.5/30). The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunisation. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. The patient experienced chest pain-radiating pain on right arm on 14Mar2021 19:30 and went to the emergency room. The event resulted in Emergency room/department or urgent care. The patient underwent EKG, Chest X-Ray, Blood work on an unspecified date with unknown results. The outcome of the events was recovering. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since vaccination.
Patient had received 1st dose on 21-Jan-2021 and 2nd dose on 21-Apr-2021; This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient had received 1st dose on 21-Jan-2021 and 2nd dose on 21-Apr-2021) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20DA and 032120A) for COVID-19 prophylaxis.     Concurrent medical conditions included Type 2 diabetes mellitus and Retinopathy diabetic (Diabetes Adult Type-2 Chronic). Concomitant products included LISINOPRIL, AMLODIPINE BESYLATE, METFORMIN HCL, ACETYLSALICYLIC ACID (BAYER LOW DOSE) and DULAGLUTIDE (TRULICITY) for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient had received 1st dose on 21-Jan-2021 and 2nd dose on 21-Apr-2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient had received 1st dose on 21-Jan-2021 and 2nd dose on 21-Apr-2021) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: from 130 to 141 with a range of 146 to 182 From 130 to 141 with a range of 146 to 182.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had no allergies to medications, food and other products. Patient had not tested positive for COVID-19.  Other concomitant medications included Statin 5mg per day.  No treatment information was provided.   This case was linked to MOD-2022-570354 (Patient Link).
pt had swelling & redness the size of a baseball that started 1 hr p/inject lt arm deltoid area;
Dose 1: sore arm for ~36h Dose 2: sore arm  ~ 3h after injection.  Joint pain, muscle aches, headache all started within first 12h after inj. Increased body aches, muscle aches, headaches and fever started 24h after injection.  Continued for next 24h. Enlarged lymph node noted on left collarbone at 36h. Symptoms subsiding at 48h mark.
pt recvd 3rd dose of vax 10NOV95 930AM & 1 hrs later began feeling shaky, sweaty, pt felt like couldn't breathe;given DPH, Epi, Methylprednisolone IV w/Albuterol tx
HYPOTENSION 3/1/2022  &  7/27/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
This spontaneous report was received from a pharmacist refers to a 66 year old female patient. The patient had no relevant medical history or concomitant medications. On 28-JAN-2007, the patient was vaccinated an expired dose of ZOSTAVAX (lot # L037790, expiry date: 30-DEC-2016) for prophylaxis, because of a prescription received from the doctor. It is unknown if there was relevant lab work. Additional information has been requested.
On 11/14/21 pt experienced a massive stroke. History provided by patient's Son. Per his report, patient had some URI symptoms for about a week with some antibiotics. Son went to see patient 11/14 PM and around 1830, patient suddently became very confused, vomited, had difficulty breathing and Son called EMS. In ER, patient was found to have sepsis with possible aspiration pneumonia, NSTEMI, Massive CVA (Large right PCA infarct) and had a seizure in ER, AKI. Patient now has a LV thrombus. Patient still has a poor prognosis and still intubated.
Large red area around injection site; Site is slightly swollen and warm to the touch; Site is slightly swollen and warm to the touch; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received  second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 10:15 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient had not been diagnosed with COVID-19. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 10:45 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. On 28Apr2021, 15 hours after second shot, the patient experienced large red area around injection site that appeared slightly swollen and warm to the touch. The patient was still experiencing this side effect three days later. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event large red area around injection site and slightly swollen and warm to the touch was not recovered at this time of report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Product BUD 2/23/2023 Administered on 2/28/2023
2 reactions - (1) 4cmx10cm, (2) 8cmx10cm red, swollen, and painful. Rx Augmentin.
Suspected acute disseminated encephalomyelitis. It is unknown if the vaccine was actually given- an order was placed, but record of administration unclear.
Morning after vaccine, noticed redness around injection site.  Also felt arm pain, fever, and fatigue.  Rash around site worsened on day 2 as systemic side effects improved. Arm continued to ache.  Rash continued on day 3 but pain subsided.  Itching occurred at site.  After a week, swelling around site subsided but rash has continued. Ring formed around site at around week.
Large red area on right superolateral thigh. Warm to touch - splotchiness. Diagnosis exanthem.
4-6 lt leg @ inj site-4" reddened area;3" hard-irritable last noc-temp 101 (temp 97.7) 7APR99 @ time of visit;
Started crying 3 hrs post admistration of vaccine and cried non-stop for 7 hrs. No other problems.
1 week post vaccination felt chills; 1 week post vaccination felt brain fog; Headache above eyes; Body aches; Rapid heart rate; Blood pressure increased; Tiredness; Fatigue; Day post vaccination a sore and throbing LT arm; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150) via an unspecified route of administration in the left arm on 09Apr2021 at 09:30 (at the age of 69-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, vertigo, Central Nervous System hypersensitivity, inner ear vestibulopathy, anxiety, osteopenia and hypercholesteremia. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included atorvastatin calcium (LIPITOR), calcium carbonate (CALTRATE), vitamin d not otherwise specified (VITAMIN D), alendronate sodium (FOSAMAX), ascorbic acid (VITAMIN C) and beclometasone dipropionate (QVAR); all taken for unknown indication from an unknown dates and unknown if ongoing. On 10Apr2021, a day post vaccination, the patient experienced sore and throbbing left arm. On 16Apr2021 at 22:30, 1 week post vaccination, the patient felt chills, brain fog, headache above eyes, body aches, rapid heart rate, increased blood pressure readings, tiredness and fatigue. These symptoms were lasting for 3 days and on 19apr2021 the patient felt somewhat improved although was feeling fatigued. On 16Apr2021 at 22:30, the patient underwent lab tests and procedures which included heart rate and blood pressure and the result was found to be rapid for heart rate and increased for blood pressure. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore, throbbing left arm, felt chills, brain fog, headache above eyes, body aches, rapid heart rate, increased blood pressure readings and tiredness were recovering, while the event fatigue was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
pt recv vax & devel induration @ inj site;no further details known as of the reporting date;this is 1 of 3 patients from this site who exp above rxn
A third (booster) dose of BNT162b2 was administered; Sensation on my legs; Eyes sights blurry; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2589) via an unspecified route of administration in the left arm on 27Oct2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included influenza vaccine (MANUFACTURER UNKNOWN) on 10Oct2021 for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the left arm on 16Mar2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FN6207) via an unspecified route of administration in the left arm on an unknown date in Apr2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient received flu vaccine within four weeks prior to the COVID-19 vaccine. On an unknown date in Oct2021, the patient experienced sensation on his legs and eyes sights blurry. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in Oct2021, the patient underwent polymerase chain reaction (PCR) test via nasal swab and the result was negative. The clinical outcome of the events sensation on his legs blurry and eyes sights blurry was unknown at the time of this report.
got my shingle shot and 3 days later I got shingles; so much pain; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 3 days after receiving Shingles vaccine, the patient experienced shingles and pain. On an unknown date, the outcome of the shingles and pain were unknown.   It was unknown if the reporter considered the shingles and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 18-APR-2022 Reporter's Comment: This case was reported by the patient via interactive digital media. The patient stated that, did not fall for false hope.  The patient got his/her shingle shot and 3 days later got shingles and had them for a whole year and they opened up his/her whole right side.  It was 9 inches long 3 inches wide and 4 inches deep. This was the 4th time he/she had them.  The patient had never been in so much pain in his/her entire life.  The shot could give shingles.  The patient would not ever do that shot or any shot again. Additional Supportive Information: The follow up would not possible as no contact details were available.
COVID Breakthrough Case *************************************************************************************************************** When I was at work, I started having a dry cough. a min to two min later I would just keep coughing. Then I had runny just crazy clear nonstop snot from my nose. Then I went and took my temperature and it was 100.1. I then called my supervisor ad was instructed to go home. Made a appoint with my doctor the next day. I told them i with had the flu or COVID and as the day went by, I felt worse. they did the COVID test, and they told me to wait 5 days until I could get results. I then went home and was very dizzy and needed assistance walking around. I took my oxygen, and it was down and kept dropping.  Symptoms  Body aches  fever runny nose  cough felt very weak my balance was off  sob chest pain